Cyanobacteria: potential candidates for drug discovery

Area of Science:

• Biotechnology
• Marine Biology
• Pharmacology

Background:

• Cyanobacteria synthesize diverse bioactive molecules with significant pharmaceutical applications.
• These compounds exhibit a wide range of bioactivities, including antitumor, antiviral, and antibacterial properties.
• Existing research highlights their potential as immunosuppressive agents and multi-drug resistance reversers.

Purpose of the Study:

• To review anticancerous, antiviral, and antibacterial compounds derived from cyanobacteria.
• To discuss the clinical status of these cyanobacterial-derived compounds.
• To summarize extraction and detection techniques for cyanobacterial bioactive molecules.

Main Methods:

• Literature review of scientific databases.
• Analysis of studies on cyanobacterial compound isolation and purification.
• Evaluation of clinical trial data for cyanobacterial-derived drugs.

Main Results:

• Several cyanobacterial compounds have demonstrated potent anticancer, antiviral, and antibacterial activities.
• Some compounds have progressed to Phase II and III clinical trials, indicating therapeutic promise.
• Standardized techniques for extraction, isolation, and purification have been developed.

Conclusions:

• Cyanobacterial bioactive molecules represent a promising frontier for drug discovery.
• These compounds can serve as lead structures for developing synthetic analogs with enhanced efficacy.
• Further research into cyanobacterial natural products holds significant potential for pharmaceutical development.